Gibbs, Ebrima
Silverman, Judith M.
Zhao, Beibei
Peng, Xubiao
Wang, Jing
Wellington, Cheryl L.
Mackenzie, Ian R.
Plotkin, Steven S.
Kaplan, Johanne M.
Cashman, Neil R. http://orcid.org/0000-0002-0080-1006
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research
Fondation Brain Canada
Alberta Innovates | Alberta Innovates Bio Solutions
Article History
Received: 19 November 2018
Accepted: 25 June 2019
First Online: 8 July 2019
Competing Interests
: S.S.P., N.R.C. and J.M.K. are Chief Physics Officer, Chief Scientific Officer and Chief Development Officer of ProMIS Neurosciences, respectively. S.S.P. is the inventor on patent application PCT/CA2016/051306 for Collective Coordinates computational modeling (applicant being University of British Columbia). S.S.P., N.R.C.; S.S.P., N.R.C. are inventors on patent application PCT/CA2016/051303 (applicant being University of British Columbia) which has entered the national phase in US, CA, EP, CN, JP, AU, IN and SK, and N.R.C., S.S.P., J.M.K., E.G. and J.M.S. are inventors on patent applications US. Serial No. 16/148,601 and PCT/CA2017/050866, which has entered national phase in in US, CA, EP, CN, JP, AU, IN and SK (co-applicants for both being University of British Columbia and ProMIS Neurosciences). The patent applications describe immunogens, antibodies and methods of their making as well as their use. Patent applications owned by the University of British Columbia are licensed to ProMIS Neurosciences. The work presented was financially supported by ProMIS. E.G., J.M.S., X.P., S.S.P., J.M.K. and N.R.C. have received consultation compensation from ProMIS. E.G., J.M.S. and S.S.P. possess ProMIS stock options. N.R.C. and J.M.K. possess ProMIS shares and stock options. B.Z., J.W., C.W. and I.M. declare no competing interests.